Australia markets close in 42 minutes

Repro Med Systems, Inc. (KRMD)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.4300-0.0200 (-0.82%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
24,304
23,490
24,176
23,163
17,354
Cost of revenue
10,144
9,721
9,240
8,309
6,543
Gross profit
14,160
13,770
14,936
14,854
10,810
Operating expenses
Research development
3,285
2,474
1,297
740.475
241.124
Selling general and administrative
18,361
17,862
12,028
9,772
9,096
Total operating expenses
22,103
20,799
13,744
10,852
9,646
Operating income or loss
-7,943
-7,030
1,192
4,001
1,165
Total other income/expenses net
659.857
652.011
-2,429
-3,386
-15.69
Income before tax
-7,281
-6,364
-1,194
696.418
1,177
Income tax expense
-1,457
-1,802
17.8
132.069
266.38
Income from continuing operations
-5,824
-4,563
-1,212
564.349
910.57
Net income
-5,824
-4,563
-1,212
564.349
910.57
Net income available to common shareholders
-5,824
-4,563
-1,212
564.349
910.57
Basic EPS
-
-0.10
-0.03
0.01
0.02
Diluted EPS
-
-0.10
-0.03
0.01
0.02
Basic average shares
-
44,385
41,930
38,778
38,128
Diluted average shares
-
44,385
41,930
39,061
38,922
EBITDA
-
-6,566
1,611
4,342
1,474